calendar
8,689 catalysts · 3,086 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 583 earnings
8,689 catalysts · 3,086 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 583 earnings
Sponsor: SUN PHARM INDS INC. Form: CAPSULE. Route: ORAL
Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: APOTEX INC. Form: TABLET. Route: ORAL
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: ZYDUS PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL
Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL
Sponsor: RICONPHARMA LLC. Form: SYSTEM. Route: TRANSDERMAL
Sponsor: AMNEAL PHARMS NY. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: DR REDDYS LABS LTD. Form: CAPSULE. Route: ORAL
Sponsor: USPHARMA. Form: PATCH. Route: TOPICAL
Sponsor: RISING. Form: TABLET. Route: ORAL
Product code: DYB. Advisory committee: Cardiovascular. Type: Traditional
Product code: DQK. Advisory committee: Cardiovascular. Type: Traditional
Product code: GXY. Advisory committee: Neurology. Type: Abbreviated
Supplement type: 30-Day Notice. Product code: PHP. Advisory committee: PA. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIP. Advisory committee: CV. Decision: OK30
RefleXion X1 Radiotherapy System Model RXM1000, Part #800-00006-00 — Reason: Due to a radiotherapy medical system software defect, when performing angular roll corrections followed by a repeat localization, the roll corrections applied in the initial localization scan are not carried through to treatment delivery leading to the treatment plan dose being delivered to the incorrect location, potentially a displacement of 5mm or higher, with a 10% to 20% underdose. — Status: Ongoing
Product Name: ID NOW" Influenza A & B 2 Model/Catalog Number: 427-000 Software Version: Not Applicable Product Description: Influenza A/B virus nucleic acid IVD, kit, nucleic acid technique Component: Not Applicable — Reason: It was confirmed that the impacted lot has a higher occurrence of invalid rates when compared to the product Instructions for Use. — Status: Ongoing
AI grant. $384,939. PI: Michael James Holmes
AI grant. $332,414. PI: Michaelle Chojnacki
AI grant. $506,415. PI: Edouard G Vannier
AI grant. $409,750. PI: John D Mountz
AI grant. $842,888. PI: Sara Suliman
AI grant. $220,000. PI: Youyi Fong
AI grant. $416,894. PI: Hubert O Amrein
TR grant. $3,240,000. PI: LEE ARMISTEAD DENSON
CA grant. $5,000. PI: Priya R. Banerjee
AI grant. $226,500. PI: Roger D Pechous
AI grant. $186,758. PI: Mary O'Riordan
AI grant. $245,250. PI: Igor Kramnik
HD grant. $715,595. PI: Lisa M Bebell
HD grant. $36,131. PI: Lisa M Bebell
AI grant. $717,952. PI: ISABELLE DERRE
AI grant. $790,507. PI: Cody Jay Warren
AI grant. $232,500. PI: Mark Scott Sundrud
AI grant. $776,034. PI: Caroline Lauren Sokol
AI grant. $414,305. PI: Katherine Anne Henzler-Wildman
AI grant. $460,625. PI: Rocky Lai
AI grant. $442,758. PI: Kimberly Elizabeth Beatty
NS grant. $15,000. PI: Solange P Brown
CA grant. $12,500. PI: LAURA J ESSERMAN
Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS